About Conference

Welcome to the International Conference on Reproductive Health and Infertility (Reproductive Medicine 2024), scheduled for November 26-27, 2024, in Paris, France. This year's theme, "Advances in Enhancing Fertility and Reproductive Health," promises to be enlightening and inspiring.

Reproductive Medicine 2024 offers attendees a rich program of engaging presentations, interactive workshops, and stimulating discussions led by top experts in the field. This conference serves as a valuable platform for exchanging ideas and best practices, learning about cutting-edge developments in reproductive health, and networking with professionals from across the globe.

The event will also feature a dynamic exhibit hall where the latest products and services in reproductive health will be showcased. Attendees can explore innovative solutions, connect with exhibitors, and discover ways to enhance their own practices. Join us at Reproductive Medicine 2024 for an enriching and informative experience.

Target Audience:

• Reproductive health experts
• Obstetricians and gynecologists
• Fertility specialists
• Reproductive endocrinologists
• Reproductive scientists
• Andrologists
• Infertility counselors
• Embryologists
• Nurse practitioners
• Physician assistants
• Industry professionals
• Researchers in reproductive health and fertility
• Students and trainees in the field

Why to Attend?

There are many compelling reasons to attend the Reproductive Medicine 2024 conference:

Networking Opportunities: Connect with leading experts, researchers, and industry professionals from around the globe.

Inspiring Presentations: Experience presentations, workshops, and discussions led by renowned specialists in the field.

Hands-On Learning: Engage in practical workshops and sessions designed to provide hands-on learning experiences.

Exhibition Hall: Discover the latest products and services from top companies in reproductive medicine and fertility.

Enhance Your Skills: Broaden your knowledge, refine your skills, and advance your career.

Overall, Reproductive Medicine 2024 is an essential event for anyone looking to deepen their understanding, connect with peers, and explore innovative products and services in reproductive medicine and fertility.

Sessions & Tracks

Track 01- Reproductive Health

Reproductive health encompasses the well-being of the reproductive systems and their functions across a person’s lifespan. It involves physical, mental, and social aspects related to reproduction and encompasses a broad range of issues, from sexual health to family planning and prevention of reproductive system diseases. Reproductive health is an essential aspect of overall health, encompassing a wide range of issues and requiring comprehensive care, education, and support to ensure the well-being of individuals across their reproductive lives.

Track 02-Reproductive Endocrinology

Reproductive endocrinology is a subspecialty of endocrinology focused on diagnosing and treating hormonal disorders related to reproduction and sexual health. It addresses a range of issues affecting both male and female reproductive systems, including infertility, hormonal imbalances, and reproductive system disorders. Reproductive endocrinology plays a crucial role in managing reproductive health through specialized hormonal treatments, diagnostic tools, and personalized care strategies, addressing a wide range of conditions to support individuals in achieving optimal reproductive outcomes.

Track 03 - Assisted Reproductive Technology

Assisted Reproductive Technology (ART) encompasses a range of medical procedures used to address infertility and help individuals or couples conceive. These technologies assist with the fertilization of eggs, implantation, and the development of embryos. Assisted Reproductive Technology offers a range of options for those experiencing infertility or other reproductive challenges, providing hope and solutions through advanced medical procedures and technologies.

Common ART Procedures

• In Vitro Fertilization (IVF) A process where eggs are retrieved from the ovaries and fertilized with sperm outside the body in a laboratory. The resulting embryos are then transferred into the uterus.
• Intracytoplasmic Sperm Injection (ICSI) A specialized form of IVF where a single sperm is injected directly into an egg to facilitate fertilization.
• Intrauterine Insemination (IUI) Sperm is collected and then directly inserted into the uterus
• Sperm Donation, Embryo Donation& Artificial Insemination
• Gestational Carrier (Surrogacy)

Track 04- Advances in Fertility Treatments

Advances in fertility treatments have significantly improved the options available for individuals and couples facing challenges with conception. These advancements reflect the ongoing evolution in fertility treatments, driven by technological innovation, research, and a deeper understanding of reproductive health. They offer improved chances of conception and more personalized approaches to addressing fertility challenges.

Genetic Testing and Screening: Innovations in preimplantation genetic testing (PGT) and non-invasive prenatal testing (NIPT) to detect genetic abnormalities early.

Improved ART Techniques: Development of new methods in assisted reproductive technologies (ART), such as personalized IVF protocols and advances in embryo culture techniques.

Fertility Preservation: Techniques for preserving fertility, including egg and sperm freezing, especially for individuals undergoing medical treatments like chemotherapy.

Track 05-Endometriosis and PCOS Research

Research into endometriosis and polycystic ovary syndrome (PCOS) has seen significant advancements, focusing on understanding their underlying mechanisms, improving diagnostic methods, and developing new treatments. Here’s an overview of current research trends and breakthroughs in these two areas. Advancements in research are paving the way for better understanding, diagnosis, and treatment of endometriosis and PCOS, ultimately aiming to improve the quality of life for individuals affected by these conditions. Exploration of new treatments and management strategies for endometriosis and polycystic ovary syndrome (PCOS).Increasing awareness and education about these conditions to improve diagnosis and support.

Track 06 – Menopause

Menopause is a natural biological process marking the end of a woman’s menstrual cycles and fertility. It is diagnosed after 12 consecutive months without a menstrual period, typically occurring between the ages of 45 and 55. Menopause results from a gradual decline in ovarian hormone production, leading to the cessation of menstruation and various physiological and emotional changes. Menopause is a significant life transition that can bring about various physical and emotional changes. Understanding these changes and exploring available treatments and lifestyle modifications can help manage symptoms and support overall health and well-being during this stage of life.

Track 07- Artificial insemination

Artificial insemination (AI) is a fertility treatment that involves the introduction of sperm into a woman's reproductive tract by means other than sexual intercourse. It's used to assist couples or individuals with difficulties conceiving naturally.

Types of Artificial Insemination

• Intrauterine Insemination (IUI)
• Intracervical Insemination (ICI)
• Intra-Vaginal Insemination (IVI)

Artificial insemination is a valuable tool in the field of reproductive medicine, offering options for those facing infertility challenges. It is generally well-tolerated, with many achieving successful pregnancies through this method.

Track 08 - Gynecology & Obstetrics

Gynecology is the branch of medicine that deals with the health of the female reproductive system, including the vagina, uterus, ovaries, and fallopian tubes. It encompasses a wide range of medical conditions, screenings, and treatments related to women's reproductive health. Obstetrics is the branch of medicine that focuses on pregnancy, childbirth, and the postpartum period. Obstetricians provide care for pregnant women and manage labor and delivery, as well as any complications that may arise during these times. Gynecology focuses on the broader aspects of women's reproductive health, while obstetrics centers specifically on pregnancy and childbirth. Both fields are essential for maintaining overall women's health and addressing various reproductive and maternal needs.

Track 09- Pregnancy

Pregnancy is a complex physiological process that involves the development of an embryo and fetus within the uterus, culminating in childbirth. It is typically divided into three trimesters, each marked by distinct developmental stages and changes for both the mother and the baby. Pregnancy is a unique and transformative experience, requiring careful monitoring and care to ensure the health and well-being of both the mother and the baby. Regular prenatal care, a healthy lifestyle, and understanding the stages of pregnancy help support a positive and healthy pregnancy journey.

Track 10- Reproductive cancers

Reproductive cancers refer to cancers that affect the reproductive organs in both men and women. These cancers can impact various parts of the reproductive system and may present with different symptoms, risk factors, and treatment approaches. Reproductive cancers can significantly impact physical health and emotional well-being. Early detection and treatment are crucial for improving outcomes, and regular screenings and awareness of symptoms can play a key role in effective management.

Track 11- Reproductive Medicine

Reproductive Medicine is a specialized field of medicine that focuses on diagnosing and treating conditions related to reproduction and fertility. It encompasses a wide range of services aimed at helping individuals and couples conceive, manage reproductive health, and address issues related to infertility. Reproductive medicine is a dynamic and multifaceted field that addresses a broad spectrum of issues related to fertility, reproductive health, and hormonal balance. Advances in technology and research continue to improve treatment options and outcomes for individuals and couples seeking to build families or manage reproductive health challenges.

Track 12- Sexually Transmitted Diseases

Sexually transmitted diseases (STDs), also known as sexually transmitted infections (STIs), are infections that are primarily spread through sexual contact. They can affect various parts of the body and can lead to a range of symptoms or no symptoms at all. Early detection and treatment are crucial for managing STDs and preventing complications. Common Sexually Transmitted Diseases are Chlamydia, Gonorrhea, Syphilis, Human Papillomavirus (HPV), Herpes Simplex Virus (HSV), Human Immunodeficiency Virus (HIV), Hepatitis B, Hepatitis C .

Sexually transmitted diseases can have significant health implications if left untreated, but with early detection and proper treatment, many can be managed effectively. Regular screenings, safe sex practices, and education play key roles in prevention and maintaining sexual health.

Track 13- Urogenital disorders

Urogenital disorders encompass a wide range of conditions affecting the urinary and reproductive systems in both men and women. These disorders can impact various aspects of health, including urinary function, sexual health, and reproductive capabilities. Some of the urogenital disorders are Urinary Tract Infections , Incontinence , Kidney Stones , Benign Prostatic Hyperplasia , Prostatitis , Erectile Dysfunction , Polycystic Ovary Syndrome , Pelvic Inflammatory Disease , Testicular Disorders , Sexual Dysfunction.

 Urogenital disorders can significantly impact quality of life and overall health. Timely diagnosis, appropriate treatment, and preventive measures are essential for managing these conditions and maintaining reproductive and urinary health.

Track 14- Reproductive Technology

Reproductive technology encompasses a range of medical techniques and procedures designed to assist individuals and couples in achieving pregnancy and managing reproductive health. These technologies are particularly valuable for addressing infertility, genetic issues, and other reproductive challenges. Key reproductive technologies are In Vitro Fertilization, Intracytoplasmic Sperm Injection , Preimplantation Genetic Testing , Surrogacy , Uterine Transplant , Sperm Retrieval Techniques, Fertility Preservation.

Reproductive technologies have transformed the field of fertility and reproductive health, offering new opportunities for individuals and couples facing reproductive challenges. Ongoing advancements continue to improve the effectiveness and accessibility of these technologies.

Track 15- Infertility & Related Disorders

Infertility is a condition characterized by the inability to conceive after 12 months of regular, unprotected intercourse for women under 35, or after 6 months for women over 35. It can result from various factors affecting either partner or both. Understanding the underlying causes is crucial for effective treatment and management. Effective management of infertility requires a comprehensive approach tailored to the specific needs of the individual or couple. Advances in medical science continue to improve the success rates of treatments and offer new hope for those struggling with infertility.

Diagnosis of Infertility

Female Infertility Tests

Ovulation Testing: Methods include tracking basal body temperature, ovulation predictor kits, and blood tests to measure hormone levels (e.g., LH, FSH, estrogen, and progesterone).

Imaging Tests:

• Transvaginal Ultrasound: Assesses the ovaries, uterus, and antral follicle count.
• Hysterosalpingography (HSG): An X-ray procedure to evaluate the fallopian tubes and uterine cavity.
• Sonohysterography: Uses ultrasound with saline infusion to evaluate the uterine cavity.
• Magnetic Resonance Imaging (MRI): Detailed imaging for complex cases.
• Ovarian Reserve Testing: Blood tests to measure levels of AMH (Anti-Müllerian Hormone) and antral follicle count via ultrasound.
• Hormonal Testing: Evaluates thyroid function, prolactin levels, and other hormonal imbalances.

Male Infertility Tests

Semen Analysis: Evaluates sperm count, motility, morphology, and volume.

Hormonal Testing: Blood tests to measure testosterone, FSH, LH, and prolactin levels.

Genetic Testing: Identifies genetic abnormalities that may affect fertility.

Track 16- Breast Cancer during Pregnancy

Breast cancer during pregnancy, although rare, presents unique challenges due to the need to balance effective cancer treatment with the safety of the developing fetus. Managing breast cancer during pregnancy requires a careful and individualized approach to ensure the best possible outcomes for both the mother and the baby. Close coordination among healthcare providers, timely diagnosis, and appropriate treatment adjustments are key to navigating this complex situation. Advances in medical research continue to provide new insights and options for women facing this challenging diagnosis.

Track 17 - In-Vitro Fertilization

In-Vitro Fertilization (IVF) is a complex series of procedures used to assist with the conception of a child. It is one of the most well-known and widely used types of assisted reproductive technology (ART). IVF involves combining eggs and sperm outside the body in a laboratory, and then transferring the resulting embryos into the uterus. IVF has revolutionized the field of reproductive medicine, offering hope to many couples facing infertility. The process involves multiple steps, from ovarian stimulation to embryo transfer, each critical to the success of the treatment. Advances in technology and techniques continue to improve outcomes, making IVF a viable option for many individuals and couples. Despite the challenges and risks, IVF remains a cornerstone of assisted reproductive technology, helping to build families worldwide.

Track 18- Contraception and Family Planning

Contraception refers to methods and devices used to prevent pregnancy. It plays a crucial role in family planning, allowing individuals and couples to decide if and when they want to have children. The choice of contraception depends on various factors, including health conditions, lifestyle, convenience, and personal preferences.

Family planning involves strategies and methods used to control the timing and spacing of pregnancies, as well as to achieve or prevent conception. It encompasses a range of services and practices designed to support individuals and couples in making informed decisions about their reproductive health. Family planning encompasses a wide range of services and practices that allow individuals and couples to anticipate and attain their desired number of children, as well as the spacing and timing of their births. It involves the use of contraceptive methods, fertility awareness, and education to promote informed and responsible reproductive health decisions.

Track 19 - Maternal-Fetal Medicine

Maternal-Fetal Medicine (MFM) is a subspecialty of obstetrics that focuses on managing health concerns of the mother and fetus before, during, and shortly after pregnancy. MFM specialists, also known as perinatologists, are trained to handle high-risk pregnancies and complex conditions that can affect both mother and baby. Maternal-Fetal Medicine is a critical field dedicated to ensuring the health and well-being of both mother and fetus in high-risk pregnancies. Through advanced diagnostic techniques, personalized care plans, and multidisciplinary collaboration, MFM specialists play a vital role in managing complex pregnancies and improving outcomes for families.

Track 20: Abortions and Women's Health

Abortion is the termination of a pregnancy before the fetus can live independently outside the womb. It can be performed through medication or surgical procedures, and it is a critical aspect of reproductive health. Access to safe and legal abortion services is a significant component of women's healthcare, influencing their physical, emotional, and social well-being. Abortion is a complex and multifaceted issue that intersects with women's health, rights, and access to care. Safe and legal abortion services are crucial for ensuring reproductive health and autonomy. Providing comprehensive support, accurate information, and access to care is essential for addressing the needs of women seeking abortions and ensuring their overall well-being.

Market Analysis

The global fertility market was valued at USD 35.49 billion in 2023 and is projected to reach USD 71.24 billion by 2033, growing at a notable CAGR of 7.01% from 2024 to 2033. Europe dominated the market with a leading share of 55.13% in 2023. Within the market, the assisted reproductive technology (ART) segment held the largest share, accounting for 88.21% in 2023. Fertility clinics were the top end users, capturing 74.99% of the revenue in the same year.The European fertility market was valued at USD 19.57 billion in 2023 and is expected to grow to approximately USD 39.7 billion by 2033, at a CAGR of 7.12% during the forecast period. The demand for fertility treatments in Europe has surged in recent years, driven by factors such as changing lifestyles, delayed childbearing and rising infertility rates. However, regulations for fertility treatments vary across European countries.

The Asia Pacific region is expected to grow at the fastest CAGR of 9.9% during the forecast period. Factors such as delayed childbirth, lifestyle changes, and increasing infertility rates have driven the demand for fertility treatments. Advances in assisted reproductive technologies (ART), including intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and in vitro fertilization (IVF), have improved the accessibility and effectiveness of these treatments. Additionally, financial assistance and subsidies from various governments in the Asia Pacific region have made fertility treatments more affordable for couples.

Ongoing research and development in the healthcare sector, particularly in infertility treatment, are anticipated to further boost industry growth. In developed countries like the U.S. and Canada, the costs of healthcare treatments and services are relatively high due to the availability of advanced healthcare infrastructure. The continuous advancements in healthcare technology have led to the daily use of sophisticated tools and apps worldwide. However, emerging economies such as India and China present significant opportunities for key players in the fertility market.